格隆汇11月27日丨戴维医疗(300314.SZ)公布，近日取得由国家药品监督管理局颁发的1项《医疗器械变 更注册（备案）文件》，公司产品婴儿辐射保暖台完成了医疗器械产品注册变更。上述医疗器械注册 证"产品技术要求"的变更，符合公司的生产经营实际，对公司发展具有积极影响，但尚无法预测上述变 更事宜对公司未来营业收入的影响，敬请广大投资者予以关注并注意投资风险 ...

Core Viewpoint - David Medical's stock closed at 14.82 yuan, down 1.53%, with a rolling PE ratio of 102.30 times, indicating a high valuation compared to the industry average [1][2] Company Overview - David Medical specializes in obstetric and pediatric care equipment, minimally invasive surgical instruments, and emergency ICU products, including incubators, warming devices, jaundice treatment equipment, and various monitoring devices [1] - The company has received multiple honors, including recognition as a "Manufacturing Industry Single Champion Cultivation Enterprise" and "AAA Credit Rating Enterprise" [1] Financial Performance - In Q1 2025, the company reported revenue of 1.21 billion yuan, a year-on-year decrease of 22.00%, and a net profit of 22.57 million yuan, down 40.78% [2] - The gross profit margin for the company stood at 57.13% [2] Market Position - David Medical's PE ratio of 102.30 is significantly higher than the industry average of 59.32 and the median of 39.97, placing it at the 105th position in the industry ranking [1][2] - The total market capitalization of David Medical is 4.268 billion yuan [1][2] Shareholder Information - As of August 8, 2025, the number of shareholders for David Medical is 22,500, a decrease of 1,400 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1]

Core Viewpoint - David Medical's stock closed at 15.05 yuan, with a PE ratio of 103.88 times, significantly higher than the industry average of 59.49 times, indicating potential overvaluation in the context of its financial performance [1][2] Company Summary - David Medical specializes in obstetric and pediatric care equipment, minimally invasive surgical instruments, and emergency ICU products, with key products including incubators, warming devices, jaundice treatment equipment, and various monitoring devices [1] - The company has received multiple accolades, including recognition as a "Manufacturing Industry Single Champion Cultivation Enterprise" by the Ministry of Industry and Information Technology, and has been awarded "Zhejiang Province Famous Trademark" and "AAA Credit Rating Enterprise" [1] Financial Performance - For Q1 2025, the company reported revenue of 121 million yuan, a year-on-year decrease of 22.00%, and a net profit of 22.57 million yuan, down 40.78% from the previous year, with a gross margin of 57.13% [2] - The company's PE ratio (TTM) stands at 103.88, while the industry average is 59.49, indicating a significant premium on its valuation compared to peers [2]

Group 1 - The core viewpoint of the news is that David Medical has a high PE ratio compared to its industry peers, indicating potential overvaluation despite its recognition as a leading manufacturer in the medical device sector [1][2] - As of August 15, David Medical's stock closed at 14.87 yuan, with a PE ratio of 102.64 and a total market capitalization of 4.283 billion yuan [1] - The average PE ratio for the medical device industry is 56.58, with a median of 39.97, positioning David Medical at the 105th rank within the industry [1][2] Group 2 - In the latest quarterly report for Q1 2025, the company reported revenue of 121 million yuan, a year-on-year decrease of 22.00%, and a net profit of 22.57 million yuan, down 40.78% [2] - The company's gross profit margin stands at 57.13%, indicating a relatively healthy margin despite the decline in revenue and profit [2] - David Medical specializes in obstetric and pediatric care equipment, minimally invasive surgical instruments, and emergency ICU products, with a range of key products including incubators and neonatal monitoring devices [1]

Core Viewpoint - David Medical's stock closed at 15.24 yuan, down 2.62%, with a rolling PE ratio of 105.19 times, significantly higher than the industry average of 57.48 times [1][2] Company Summary - David Medical specializes in obstetric and pediatric care equipment, minimally invasive surgical instruments, and emergency ICU products, including incubators, warming devices, jaundice treatment equipment, and various monitoring devices [1] - The company has received multiple honors, including recognition as a "Manufacturing Industry Single Champion Cultivation Enterprise" by the Ministry of Industry and Information Technology, and has been awarded "Zhejiang Province Famous Trademark" and "AAA Credit Rating Enterprise" [1] Financial Performance - In the latest quarterly report for Q1 2025, the company reported revenue of 121 million yuan, a year-on-year decrease of 22.00%, and a net profit of 22.57 million yuan, down 40.78% [2] - The sales gross margin for the same period was 57.13% [2] Industry Comparison - David Medical ranks 105th in terms of PE ratio within the medical device industry, where the median PE ratio is 40.95 times [1][2] - The industry average PE ratio is 57.48 times, indicating that David Medical's valuation is significantly above the industry norms [2]

最新一期业绩显示，2025年一季报，公司实现营业收入1.21亿元，同比-22.00%；净利润2256.77万元， 同比-40.78%，销售毛利率57.13%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13戴维医疗108.0278.713.7845.07亿行业平均 57.5153.344.97120.28亿行业中值41.2539.962.9558.75亿1九安医疗11.2611.380.89189.95亿2英科医疗 15.0516.231.34237.81亿3山东药玻16.1716.221.86152.96亿4新华医疗16.9415.701.38108.60亿5振德医疗 17.3716.371.1063.04亿6奥美医疗17.5417.191.8063.39亿7九强生物17.9216.672.2088.77亿8康德莱 18.7518.761.5540.40亿9维力医疗18.7920.082.3644.05亿10奥泰生物19.3120.361.5661.58亿11鱼跃医疗 20.2319.842.73358.29亿12安图生物21.1920.232.72241.60亿 8月12日，戴维医疗今日收盘1 ...

8月11日，戴维医疗今日收盘15.25元，上涨10.03%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到105.26倍，创388天以来新低，总市值43.92亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入1.21亿元，同比-22.00%；净利润2256.77万元， 同比-40.78%，销售毛利率57.13%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13戴维医疗105.2676.703.6843.92亿行业平均 56.5652.664.92118.97亿行业中值39.7639.192.9457.67亿1九安医疗11.2811.400.89190.28亿2英科医疗 15.1416.331.35239.25亿3山东药玻16.1616.211.86152.83亿4振德医疗16.7615.801.0760.86亿5新华医疗 17.1715.911.40110.05亿6奥美医疗17.1816.831.7762.06亿7九强生物17.8916.632.1988.59亿8康德莱 18.3218.341.5239.49亿9维力医疗18.6219.892.3443.64亿10奥泰生物1 ...

Group 1 - The stock price of David Medical reached 14.11 yuan as of August 4, 2025, with an increase of 0.03 yuan from the previous trading day [1] - The company operates in the medical device sector, focusing on the research and manufacturing of infant care equipment, including incubators and radiant warmers for newborns [1] - The latest data indicates a total market capitalization of 4.064 billion yuan and a price-to-earnings ratio of 45.02 [1] Group 2 - The HLD series medical isolation pad, referred to as the "baby nest," provides tactile stimulation and a sense of security for infants, effectively regulating heart rate, respiratory rate, and improving sleep quality [1] - On August 4, there was a net outflow of 22.0897 million yuan in main funds, accounting for 1.09% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow was 18.7868 million yuan, representing 0.93% of the circulating market value [1]

Group 1 - The core stock price of David Medical as of July 31, 2025, closed at 14.21 yuan, down 3.00% from the previous trading day, with a trading volume of 370 million yuan [1] - The stock experienced significant volatility during the day, with a high of 14.98 yuan and a low of 14.21 yuan, resulting in a fluctuation of 5.26% [1] - David Medical specializes in the research, production, and sales of medical devices, primarily focusing on neonatal medical equipment such as incubators and radiant warmers [1] Group 2 - On July 31, the stock showed rapid fluctuations, with a rebound of over 2% within 5 minutes in the morning session, followed by a quick decline of over 2% within the next 5 minutes, indicating active market trading [1] - The net outflow of main funds was 9.0994 million yuan, accounting for 0.45% of the circulating market value, suggesting market divergence regarding the short-term outlook of the stock [1]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of David Medical, indicating a significant decline in revenue and profit compared to the previous year [1][2] - As of July 28, David Medical's stock closed at 14.48 yuan, with a 6.55% increase, and a rolling PE ratio of 99.95, marking a new low in 198 days, with a total market capitalization of 4.17 billion yuan [1] - The company operates in the medical device industry, focusing on obstetric and pediatric care equipment, minimally invasive surgical instruments, and emergency ICU products [1] Group 2 - For the first quarter of 2025, David Medical reported a revenue of 121 million yuan, a year-on-year decrease of 22.00%, and a net profit of 22.57 million yuan, down 40.78% [2] - The company's sales gross margin stands at 57.13% [2] - In terms of industry comparison, the average PE ratio for the medical device sector is 55.28, while the median is 38.06, placing David Medical at the 104th position in the industry ranking [1][2]